Bovine Serum Albumin News and Research

RSS

NIST team demonstrates a method for controlling different-sized nanoparticle production

The same properties that make engineered nanoparticles attractive for numerous applications-small as a virus, biologically and environmentally stabile, and water-soluble-also cause concern about their long-term impacts on environmental health and safety.

3 Feb 2011

Scientists develop laser activated carbon nanoparticles for drug, gene delivery

Using chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells.Carbon nanoparticles activated by bursts of laser light trigger the tiny blasts, which open holes in cell membranes just long enough to admit therapeutic agents contained in the surrounding fluid. By adjusting laser exposure, the researchers administered a small-molecule marker compound to 90 percent of targeted cells - while keeping more than 90 percent of the cells alive.

28 Jul 2010

LBL signs strategic partnership agreement with Proliant

Lampire Biological Laboratories announced today that it signed an agreement with Proliant Health and Biologicals, manufacturer of the worlds most trusted, high quality Bovine Serum Albumin, to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.

22 Jul 2010

CryoLife purchases patent involving formulation, use of recombinant human serum albumin and gluteraldehyde

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company whose products include BioGlue Surgical Adhesive, announced today that it has completed the purchase of U.S. patent # 6,329,337. The patent involves the formulation and use of recombinant human serum albumin and gluteraldehyde, and now becomes part of CryoLife's protein hydrogel patent portfolio, which includes BioGlue.

7 Jun 2010

Singapore scientists synthesize gold to shed light on cells' inner workings

Highly fluorescent gold nanoclusters for sub-cellular imaging have been synthesized by researchers at the Institute of Bioengineering and Nanotechnology (IBN), one of the research institutes of Singapore's A*STAR (Agency for Science, Technology and Research).

16 Apr 2009

New nanofibers spun from a common blood protein to close wounds with minimal scarring

Researchers at the Technion-Israel Institute of Technology have developed a strong, flexible, bio-material that may be used someday to close wounds with minimal scarring and rejection by the immune system.

12 Nov 2008

Newly discovered testosterone effect may act on prostate cancer

A newly-discovered mode of action of testosterone is showing great promise in the fight against prostate cancer, with tests showing a 60% reduction in tumor size in mice.

6 Apr 2006

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

ProMetic Life Sciences Inc. has announced today that its joint venture with the American Red Cross, Pathogen Removal and Diagnostic Technology Inc. ("PRDT"), has confirmed that treatment of TSE spiked red blood cell concentrate with its Prion Reduction Device results in a significant decrease in associated infectivity.

5 Apr 2004

Bovine Serum Albumin News and Research

NIST team demonstrates a method for controlling different-sized nanoparticle production

Scientists develop laser activated carbon nanoparticles for drug, gene delivery

LBL signs strategic partnership agreement with Proliant

CryoLife purchases patent involving formulation, use of recombinant human serum albumin and gluteraldehyde

Singapore scientists synthesize gold to shed light on cells' inner workings

New nanofibers spun from a common blood protein to close wounds with minimal scarring

Newly discovered testosterone effect may act on prostate cancer

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News